We found that rapamycin suppresses IGF-1 stimulated F-actin reorganization and migration in various tumor cell lines by inhibiting mTORC1-mediated 4E-BP1 and S6K1 pathways [23]. Here, RPS6KB1 is linked to neoplasm.